[May (must?) in a for recurrent thrombophlebitis [with normal AT III/ protein C+S] fully "marcumarized" patient (with [otherwise?] negative contraindications) with acute posterior wall infarct (15 min "old") a brief lysis therapy be instituted?].
Seitz
R
R
Zentrum Innere Medizin, Schwerpunkt Hämatologie/Onkologie, Klinikum, Philipps-Universität, Marburg.
D000990:Antithrombin III / Q000032:analysis*; D000075202:Contraindications; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D010644:Phenprocoumon / Q000008:administration & dosage* / Q000009:adverse effects; D011486:Protein C / Q000032:analysis*; D017293:Protein S / Q000032:analysis*; D012307:Risk Factors; D015912:Thrombolytic Therapy; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D011486:Protein C; D017293:Protein S; D000990:Antithrombin III; D010959:Tissue Plasminogen Activator; D010644:Phenprocoumon
Darf (muss?) bei einem wegen rezid.Beinvenentrhombosen [bei normalem ATIII/Protein C+S] voll "marcumarisierten" Patienten (bei [sonst?] fehlenden Kontraindikationen) bei frischen Hinterwandinfarkt (15 min "alt") eine Kurzlyse durchgeführt werden?